Deciphera Pharmaceuticals (DCPH)
13.46
+0.11 (0.82%)
Upcoming Events
Latest Headlines
Form 4 Deciphera Pharmaceutical For: Jun 23 Filed by: Squarer Ron
June 24, 2022 4:06 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 23 Filed by: Walsh Dennis Leo
June 24, 2022 4:06 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 23 Filed by: Bristol James Arthur
June 24, 2022 4:06 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 23 Filed by: Martin John Richard
June 24, 2022 4:06 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 23 Filed by: Kelley Susan L.
June 24, 2022 4:06 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 23 Filed by: Benz Edward J. JR
June 24, 2022 4:06 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 23 Filed by: Friedman Franklin Stuart
June 24, 2022 4:06 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 23 Filed by: Allen Patricia L
June 24, 2022 4:06 PM - SEC Filing
Form 8-K Deciphera Pharmaceutical For: Jun 23
June 24, 2022 4:02 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 16 Filed by: Sherman Matthew L
June 21, 2022 4:38 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 16 Filed by: Pitman Jama
June 21, 2022 4:37 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 16 Filed by: Martin Daniel C.
June 21, 2022 4:36 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 16 Filed by: Kelly Thomas Patrick
June 21, 2022 4:35 PM - SEC Filing
Form 4 Deciphera Pharmaceutical For: Jun 16 Filed by: Flynn Daniel Lee
June 21, 2022 4:35 PM - SEC Filing
Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer
June 16, 2022 7:00 AM - BizWire
Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences
June 2, 2022 7:00 AM - BizWire
Form SC 13G Deciphera Pharmaceutical Filed by: Redmile Group, LLC
May 9, 2022 5:16 PM - SEC Filing
Deciphera Pharmaceuticals (DCPH) Tops Q1 EPS by 10c
May 4, 2022 7:15 AM - StreetInsider
Form 10-Q Deciphera Pharmaceutical For: Mar 31
May 4, 2022 7:14 AM - SEC Filing
Form 8-K Deciphera Pharmaceutical For: May 04
May 4, 2022 7:10 AM - SEC Filing
Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results
May 4, 2022 7:00 AM - BizWire
Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022
May 2, 2022 8:00 AM - BizWire
Form 4 Deciphera Pharmaceutical For: Apr 29 Filed by: Brightstar Associates LLC
April 29, 2022 4:45 PM - SEC Filing
Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
April 29, 2022 4:05 PM - BizWire
Form 8-K Deciphera Pharmaceutical For: Apr 26
April 28, 2022 6:17 AM - SEC Filing
Form 424B5 Deciphera Pharmaceutical
April 28, 2022 6:10 AM - SEC Filing
Deciphera Pharmaceuticals (DCPH) Prices $150M Share and Warrant Offering at $10/sh
April 27, 2022 5:43 AM - StreetInsider
Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants
April 27, 2022 12:02 AM - BizWire
Form 424B5 Deciphera Pharmaceutical
April 26, 2022 4:25 PM - SEC Filing
Deciphera Pharmaceuticals (DCPH) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
April 26, 2022 4:10 PM - StreetInsider
Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
April 26, 2022 4:10 PM - BizWire
Form 8-K Deciphera Pharmaceutical For: Apr 26
April 26, 2022 4:02 PM - SEC Filing
Form DEFA14A Deciphera Pharmaceutical
April 26, 2022 7:40 AM - SEC Filing
Form DEF 14A Deciphera Pharmaceutical For: Jun 23
April 26, 2022 7:37 AM - SEC Filing
Deciphera Pharmaceuticals (DCPH) Presents Preclinical Data from DCC-3116 Program at the AACR Annual Meeting
April 12, 2022 3:50 PM - StreetInsider
Deciphera Pharmaceuticals Presents Preclinical Data from DCC-3116 Program at the AACR Annual Meeting
April 12, 2022 3:50 PM - BizWire
Full Article List
